Further, HDAC inhibitors such as TSA can up-regulate RECK via transcriptional activation in CL-1 human lung cancer cells, as well as rescue hypoxia-suppressed RECK expression in the H-Ras-transformed human breast MCF10A and HT1080 human fibrosarcoma cell lines [31,45]. Here, RECK is linked to lung cancer.